نتایج جستجو برای: polycystic ovary syndrome premenopausal breast cancer endocrine disorder
تعداد نتایج: 2118010 فیلتر نتایج به سال:
This review describes the aetiology and pathogenesis of polycystic ovary syndrome (PCOS) and evaluates the use of acupuncture to prevent and reduce symptoms related with PCOS. PCOS is the most common female endocrine disorder and it is strongly associated with hyperandrogenism, ovulatory dysfunction and obesity. PCOS increases the risk for metabolic disturbances such as hyperinsulinaemia and in...
background: polycystic ovary syndrome (pcos) is a complex, multifaceted, heterogeneous disorder, affecting 4%-18% of reproductive-aged women and it is associated with reproductive, metabolic and psychological dysfunctions. pcos affects quality of life and can worsen anxiety and depression either due to the features of pcos or due to the diagnosis of a chronic disease. methods: in this descripti...
The objective of this review was to examine data from preclinical, clinical and epidemiological studies to evaluate if testosterone (T) poses increased risk of breast cancer in women. Appraisal of the existing literature produced several lines of evidence arguing against increased breast cancer risk with T. These include: (i) Data from breast tumor cell lines treated with androgens did not corr...
Abstract Background Polycystic ovary syndrome (PCOS) is the most typical endocrine disorder affecting women worldwide. Although etiology of PCOS not fully understood, genetic factors are believed to play an essential role in its pathogenesis. Hence, this paper presents a review outcome functional enrichment analysis pathways associated with phenotypes for identification potential molecular targ...
BACKGROUND Metabolic syndrome (defined as at least three among abdominal obesity, high blood triglycerides, low high-density lipoprotein cholesterol, high blood glucose, and high blood pressure) is emerging as a risk factor for breast cancer; however few studies - most confined to postmenopausal women - have investigated associations between breast cancer risk and metabolic syndrome. The purpos...
Luteinising hormone releasing hormone agonists (LH-RHa) are effective in the treatment of advanced endocrine-sensitive breast cancer in premenopausal patients, but their role in the adjuvant setting has remained controversial for a long time. Tamoxifen for 5 years has been traditionally considered the standard endocrine therapy for premenopausal patients and this is still valid for many patient...
Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder with disrupted uterus structure and function. A positive effect of vitamin D3 (VD3) in female reproduction was observed. Chemerin (RARRES2) adiponectin (ADIPOQ) are the main adipokines whose levels altered PCOS patients. Therefore, aim this study to investigate impact VD3 supplementation on RARRES2 ADIPOQ rats. Methods: We an...
Polycystic ovary syndrome (PCOS) is a true syndrome, being a heterogeneous collection of signs and symptoms that gathered together form a spectrum of a disorder with a mild presentation in some, whilst in others there is a severe disturbance of reproductive, endocrine and metabolic function. There has been much debate about phenotype and, more recently, genotype. There has also been scepticism ...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید